SE393981B - Sett att framstella indolylettiksyraderivat med terapeutiska egenskaper - Google Patents

Sett att framstella indolylettiksyraderivat med terapeutiska egenskaper

Info

Publication number
SE393981B
SE393981B SE7110780A SE1078071A SE393981B SE 393981 B SE393981 B SE 393981B SE 7110780 A SE7110780 A SE 7110780A SE 1078071 A SE1078071 A SE 1078071A SE 393981 B SE393981 B SE 393981B
Authority
SE
Sweden
Prior art keywords
indolyletic
preparing
acid derivatives
therapeutic properties
therapeutic
Prior art date
Application number
SE7110780A
Other languages
English (en)
Swedish (sv)
Inventor
M Kimura
S Inaba
H Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7519870A external-priority patent/JPS4946319B1/ja
Priority claimed from JP7581870A external-priority patent/JPS494474B1/ja
Priority claimed from JP8696470A external-priority patent/JPS4939279B1/ja
Priority claimed from JP10976970A external-priority patent/JPS4932876B1/ja
Priority claimed from JP10977170A external-priority patent/JPS4935000B1/ja
Priority claimed from JP10976870A external-priority patent/JPS494476B1/ja
Priority claimed from JP688771A external-priority patent/JPS4939261B1/ja
Priority claimed from JP749271A external-priority patent/JPS4932848B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE393981B publication Critical patent/SE393981B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Semiconductor Integrated Circuits (AREA)
SE7110780A 1970-08-26 1971-08-25 Sett att framstella indolylettiksyraderivat med terapeutiska egenskaper SE393981B (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP7519870A JPS4946319B1 (xx) 1970-08-26 1970-08-26
JP7581870A JPS494474B1 (xx) 1970-08-27 1970-08-27
JP8696470A JPS4939279B1 (xx) 1970-10-03 1970-10-03
JP10976970A JPS4932876B1 (xx) 1970-12-09 1970-12-09
JP10977170A JPS4935000B1 (xx) 1970-12-09 1970-12-09
JP10976870A JPS494476B1 (xx) 1970-12-09 1970-12-09
JP688771A JPS4939261B1 (xx) 1971-02-15 1971-02-15
JP749271A JPS4932848B1 (xx) 1971-02-16 1971-02-16

Publications (1)

Publication Number Publication Date
SE393981B true SE393981B (sv) 1977-05-31

Family

ID=27571590

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7110780A SE393981B (sv) 1970-08-26 1971-08-25 Sett att framstella indolylettiksyraderivat med terapeutiska egenskaper

Country Status (15)

Country Link
US (1) US3812112A (xx)
AT (1) AT307411B (xx)
AU (1) AU432570B2 (xx)
CA (1) CA988516A (xx)
CH (1) CH563978A5 (xx)
CS (1) CS196445B2 (xx)
FI (1) FI54917C (xx)
GB (1) GB1336913A (xx)
HU (1) HU163443B (xx)
IL (1) IL37586A (xx)
NL (1) NL166474C (xx)
NO (1) NO135869C (xx)
PH (1) PH9962A (xx)
PL (1) PL88941B1 (xx)
SE (1) SE393981B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
DK156439C (da) * 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
EP0488144A1 (en) * 1990-11-26 1992-06-03 Tsumura & Co. Benzodioxole derivatives and hepatopathy improvers comprising the same
CA2431023A1 (en) * 2000-12-18 2002-06-27 Eli Lilly And Company Substituted benzoindoles as spla2 inhibitors

Also Published As

Publication number Publication date
DE2142196A1 (de) 1972-03-02
NL7111679A (xx) 1972-02-29
PH9962A (en) 1976-06-16
GB1336913A (en) 1973-11-14
DE2142196B2 (de) 1975-06-26
PL88941B1 (en) 1976-10-30
HU163443B (xx) 1973-08-28
AU432570B2 (en) 1973-03-01
FI54917C (fi) 1979-04-10
NO135869C (xx) 1977-06-15
CA988516A (en) 1976-05-04
NO135869B (xx) 1977-03-07
IL37586A0 (en) 1971-11-29
NL166474C (nl) 1981-08-17
US3812112A (en) 1974-05-21
CH563978A5 (xx) 1975-07-15
AT307411B (de) 1973-05-25
NL166474B (nl) 1981-03-16
FI54917B (fi) 1978-12-29
AU3266671A (en) 1973-03-01
IL37586A (en) 1975-03-13
CS196445B2 (en) 1980-03-31

Similar Documents

Publication Publication Date Title
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE389670B (sv) Forfarande for framstellning av aroyl-substituerade pyrroler med terapeutisk verkan
CS194155B2 (en) Method of preparing novel derivatives of 7-acylaminocephalosporanic acid
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
SE402123B (sv) Sett att framstella 7-amino-3-metylcefemforeningar
SE396753B (sv) Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
SE385707B (sv) Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat
SE393981B (sv) Sett att framstella indolylettiksyraderivat med terapeutiska egenskaper
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE397087B (sv) Forfarande for framstellning av substituerade pgf-prostaglandinforeningar med lekemedelsverkan
SE393982B (sv) Sett att framstella dihydrokinolinderivat med antioxiderande verkan
FI53967C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara bensobicykloalkanaminer
SE382063B (sv) Sett att framstella fenyl-vinylfosfonsyraderivat
SE382324B (sv) Sett att framstella amiderade fenoxipropanolaminderivat med terapeutisk anvendbarhet
SU437283A3 (ru) Способ получения производных пиридинкарбамата
SE396219B (sv) Sett att framstella pyridyl-piperazinderivat
SE385887B (sv) Forfarande for framstellning av 5-substituerad-5-fenylalkylbarbitursyra med analgetisk verkan
SE393986B (sv) Sett att framstella l-(1'-cyklohexenylglycinamido)-penicillansyra
SE390167B (sv) Sett att framstella difenylpropargylettiksyraamider med farmakologiska egenskaper
SE384854B (sv) Sett att framstella 1-bensoyloxi-2-lagalylaminobensocykloalkanderivat
SE7513236L (sv) Sett att framstella furfurylidenhydrazinderivat
SE399269B (sv) Sett att framstella pregnansyra-derivat
SE388417B (sv) Sett att framstella dosmetylretinosyraderivat
SE403102B (sv) Sett att framstella indan-1-karboxylsyraderivat